4.7 Article

Transient Lack of Glucose but not O2 is Involved in Ischemic Postconditioning-Induced Neuroprotection

Journal

CNS NEUROSCIENCE & THERAPEUTICS
Volume 19, Issue 1, Pages 30-37

Publisher

WILEY-BLACKWELL
DOI: 10.1111/cns.12033

Keywords

Glucose deprivation postconditioning; Hypoxic postconditioning; Ischemic postconditioning

Funding

  1. National Basic Research of China 973 Program [2011CB504403]
  2. National Natural Science Foundation of China [81030061, 81273506, 81202520, 81102429]
  3. Fundamental Research Funds for the Central Universities [2012FZA7002]

Ask authors/readers for more resources

Aim Cerebral ischemic postconditioning has emerged recently as a kind of endogenous strategy for neuroprotection. We set out to test whether hypoxia or glucose deprivation (GD) would substitute for ischemia in postconditioning. Methods Adult male C57BL/6J mice were treated with postconditioning evoked by ischemia (bilateral common carotid arteries occlusion) or hypoxia (8% O2) after 45-min middle cerebral arterial occlusion. Corticostriatal slices from mice were subjected to 1-min oxygen-glucose deprivation (OGD), GD, or oxygen deprivation (OD) postconditioning at 5 min after 15-min OGD. Results Hypoxic postconditioning did not decrease infarct volume or improve neurologic function at 24 h after reperfusion, while ischemic postconditioning did. Similarly, OGD and GD but not OD postconditioning attenuated the OGD/reperfusion-induced injury in corticostriatal slices. The effective duration of low-glucose (1 mmol/L) postconditioning was longer than that of OGD postconditioning. Moreover, OGD and GD but not OD postconditioning reversed the changes of glutamate, GABA, glutamate transporter-1 protein expression, and glutamine synthetase activity induced by OGD/reperfusion. Conclusions These results suggest that the transient lack of glucose but not oxygen plays a key role in ischemic postconditioning-induced neuroprotection, at least partly by regulating glutamate metabolism. Low-glucose postconditioning might be a clinically safe and feasible therapeutic approach against cerebral ischemia/reperfusion injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available